Raymond Dwek
Direktor/Vorstandsmitglied bei UNITED THERAPEUTICS CORPORATION
Vermögen: 481 478 $ am 31.05.2024
Profil
Raymond Allen Dwek founded Oxford GlycoSciences Plc in 1988.
Mr. Dwek also currently works at United Therapeutics Corp., as Independent Director from 2002.
Mr. Dwek also formerly worked at The Library of Congress (District of Columbia), as Chairman-Technology & Society, Oxford Glycobiology Institute, as Director-Emeritus from 1988 to 2021, the University of Oxford, as Professor & Head-Biochemistry Department from 2000 to 2006, and Institute of Biology, as President from 2008 to 2010.
Mr. Dwek received his undergraduate degree and graduate degree from the University of Oxford.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.04.2024 | 1 750 ( 0,00% ) | 481 478 $ | 31.05.2024 |
Aktive Positionen von Raymond Dwek
| Unternehmen | Position | Beginn |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Direktor/Vorstandsmitglied | 01.01.2002 |
Ehemalige bekannte Positionen von Raymond Dwek
| Unternehmen | Position | Ende |
|---|---|---|
| Oxford Glycobiology Institute | Direktor/Vorstandsmitglied | 01.01.2021 |
| Institute of Biology | Präsident | 01.01.2010 |
| University of Oxford | Corporate Officer/Principal | 01.01.2009 |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Direktor/Vorstandsmitglied | 01.01.2003 |
| The Library of Congress (District of Columbia) | Corporate Officer/Principal | - |
Ausbildung von Raymond Dwek
| University of Oxford | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
| The Library of Congress (District of Columbia) | Government |
| Institute of Biology |
